Indications for Morphine Sulfate Tablets:

The administration is of intense and persistent pain extremely sufficient to require an opioid pain-relieving and for which alternative medicines are lacking.

Limitations of Use:

Utilize as it were in case alternative treatment options (eg, non-opioid analgesics, opioid combination products) are incapable, not endured, or something else insufficient to provide adequate management of pain.


Use most reduced viable dosage for a most limited term. Individualize. Tabs: opioid-naive or opioid non-tolerant: at first 15–30mg each 4hrs as required. Soln: at first 10–20mg each 4hrs as required. 100mg/5mL quality: for utilize in opioid-tolerant patients as it were. Transformation to and from other morphine definitions or other opioids: see full labeling. Pull back continuously by 25–50% each 2–4 days.


<18yrs: not set up.


Critical respiratory depression. Intense or extreme bronchial asthma in an unmonitored setting or within the nonappearance of resuscitative hardware. Amid or inside 14 days of MAOIs. Known or suspected GI obstacle, counting crippled ileus.


Habit, mishandle, and abuse. Hazard assessment and relief methodology (REMS). Life-threatening respiratory sadness. Inadvertent ingestion. Neonatal opioid withdrawal disorder. Dangers from concomitant utilize with benzodiazepines or other CNS depressants.


Mishandle potential (monitor). Life-threatening respiratory sadness; screen inside to begin with 24–72hrs of starting treatment and taking after measurements increments.

The inadvertent introduction may cause deadly overdose (esp. in children). COPD, cor pulmonale, diminished respiratory save, hypoxia, hypercapnia, or pre-existing respiratory misery; screen and consider non-opioid analgesics.

Adrenal inadequate. Head harm. Expanded intracranial weight, brain tumors; monitor. Seizure disarranges. CNS sadness. Disabled awareness, coma, stun; dodge. Biliary tract malady.

Intense pancreatitis. Medicate abusers. Renal or hepatic impedance; start lower dosages and titrate gradually.

Reevaluate occasionally. Dodge sudden cessation. Elderly. Cachectic. Weakened. Pregnancy; potential neonatal opioid withdrawal disorder amid delayed utilize.

Labor & conveyance: not suggested. Nursing moms: screen newborn children.

Pharmacologic Class:

Opioid agonist.


See Contraindications. Expanded risk of hypotension, respiratory depression, sedation with benzodiazepines or other CNS depressants (eg, non-benzodiazepine sedatives/hypnotics, anxiolytics, common anesthetics, phenothiazines, tranquilizers, muscle relaxants, antipsychotics, liquor, other opioids); save concomitant utilize in those for whom elective alternatives are insufficient; restrain dosages/durations to least required; screen.

Hazard of serotonin disorder with serotonergic drugs (eg, SSRIs, SNRIs, TCAs, triptans, 5-HT3 enemies, mirtazapine, trazodone, tramadol, MAOIs, linezolid, IV methylene blue); screen and suspend on the off chance that suspected.

Maintain a strategic distance from concomitant blended agonist/antagonist opioids (eg, butorphanol, nalbuphine, pentazocine) or halfway agonist (eg, buprenorphine); may diminish impacts and accelerate withdrawal indications.

May antagonize diuretics; screen. Incapacitated ileus may happen with anticholinergics. May be potentiated by cimetidine, P-GP inhibitors; screen. May increment serum amylase.

Adverse Reactions:

Constipation, nausea, somnolence, lightheadedness, dizziness, sedation, vomiting, sweating; respiratory depression, severe hypotension, syncope.

Showing 1–20 of 58 results